A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) C07K 14/00 (2006.01) C07K 14/575 (2006.01) C07K 16/26 (2006.01) C07K 16/46 (2006.01) C12N 5/00 (2006.01) C12N 15/00 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2535748
The present invention relates to the use of mutants of parathyroid hormone- related protein, to treat disorders associated with smooth muscle cells, and to inhibit the cellular activation and proliferation thereof. The method can be employed in diverse tissues to effect therapeutic and prophylactic relief for disorders and diseases manifested by activation of smooth muscle that can lead to excessive smooth muscle proliferation. For example, where employed in the vasculature, the inventive method can be used to treat restenosis following angioplasty.
L'invention concerne l'utilisation de mutants de la protéine liée à l'hormone parathyroïde pour traiter des troubles associés aux cellules du muscle lisse, et inhiber l'activation cellulaire et la prolifération de celles-ci. Le procédé peut être appliqué dans divers tissus pour traiter et prévenir des troubles et des maladies se manifestant par l'activation du muscle lisse et pouvant entraîner une prolifération excessive de muscle lisse. Par exemple, lorsqu'on l'applique à des vaisseaux, le procédé permet de traiter la resténose consécutive à une angioplastie.
Fiaschi-Taesch Nathalie
Stewart Andrew F.
Osler Hoskin & Harcourt Llp
Vasculostatin Llc
LandOfFree
Pthrp-derived modulators of smooth muscle proliferation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pthrp-derived modulators of smooth muscle proliferation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pthrp-derived modulators of smooth muscle proliferation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1646375